AQR Capital Management
AMAG

AQR Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

AQR Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-58,993
Closed -$365K – 2192
2020
Q1 		$365K Buy
+58,993
New +$520K ﹤0.01% 1693
2019
Q3 		– Sell
-82,919
Closed -$828K – 2209
2019
Q2 		$828K Sell
82,919
-157,750
-66% -$1.7M ﹤0.01% 1564
2019
Q1 		$3.1M Buy
240,669
+44,674
+23% +$665K ﹤0.01% 1161
2018
Q4 		$2.98M Buy
+195,995
New +$3.73M ﹤0.01% 1108
2018
Q1 		– Sell
-103,114
Closed -$1.37M – 2300
2017
Q4 		$1.37M Sell
103,114
-130,205
-56% -$1.96M ﹤0.01% 1548
2017
Q3 		$4.3M Sell
233,319
-80,105
-26% -$1.49M 0.01% 1077
2017
Q2 		$5.77M Buy
313,424
+130,164
+71% +$2.58M 0.01% 972
2017
Q1 		$4.13M Buy
183,260
+116,461
+174% +$2.79M 0.01% 1094
2016
Q4 		$2.33M Sell
66,799
-6,138
-8% -$183K ﹤0.01% 1334
2016
Q3 		$1.79M Buy
72,937
+16,216
+29% +$405K ﹤0.01% 1462
2016
Q2 		$1.36M Sell
56,721
-4,812
-8% -$110K ﹤0.01% 1489
2016
Q1 		$1.44M Buy
61,533
+11,706
+23% +$278K ﹤0.01% 1424
2015
Q4 		$1.5M Sell
49,827
-33,351
-40% -$1.08M ﹤0.01% 1389
2015
Q3 		$3.3M Buy
83,178
+36,071
+77% +$2.24M 0.01% 930
2015
Q2 		$3.25M Buy
47,107
+19,767
+72% +$1.24M 0.01% 978
2015
Q1 		$1.49M Buy
27,340
+17,440
+176% +$831K ﹤0.01% 1234
2014
Q4 		$422K Buy
+9,900
New +$358K ﹤0.01% 2041
2014
Q2 		– Sell
-61,000
Closed -$1.18M – 2616
2014
Q1 		$1.18M Sell
61,000
-1,500
-2% -$31.9K ﹤0.01% 1619
2013
Q4 		$1.52M Sell
62,500
-900
-1% -$21.2K ﹤0.01% 1514
2013
Q3 		$1.36M Sell
63,400
-23,427
-27% -$554K ﹤0.01% 1490
2013
Q2 		$1.93M Buy
+86,827
New +$1.91M 0.01% 1278

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management's AMAG Position: Q2 2020 in Review

AQR Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 58,993 shares — an estimated $365K sold.

AQR Capital Management first reported a position in AMAG in Q2 2013 and held it in 21 quarters. The position peaked at $5.77M in Q2 2017. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • AQR Capital Management reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • AQR Capital Management sold 58,993 AMAG Pharmaceuticals shares in Q2 2020, an estimated $365K.
  • AQR Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • AQR Capital Management's AMAG Pharmaceuticals position peaked at $5.77M in Q2 2017.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on AQR Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.